Chemo-free approach in acute promyelocytic leukemia (APL) treatment
What novel technologies are available for myeloma?
The 20th anniversary of the German CLL Study Group and the importance of collaboration
Case study: daratumumab in a relapsed patient
2 years on: Deborah discusses her venetoclax trial and becoming MRD negative
Deborah Henderson et al.